Rhonda Patrick on health: what the evidence says · JRE #1054

What the evidence says 01 / RECORD

The claim conflates two distinct scientific questions: whether IGF-1 itself is carcinogenic, and whether meat consumption is linked to cancer risk. On IGF-1, the characterization is broadly consistent with current understanding: circulating IGF-1 is a growth-signaling hormone associated with cancer progression and risk (e.g., prostate cancer), acting primarily as a proliferative/anti-apoptotic promoter of cells that are already damaged or transformed rather than as a direct DNA-damaging carcinogen, though research continues to explore more complex mechanistic roles. However, the claim's broader implication that 'meat causes cancer' is 'not necessarily true' understates the evidence for processed meat specifically. The WHO's International Agency for Research on Cancer (IARC) classified processed meat as a Group 1 carcinogen in 2015 -- sufficient evidence it causes colorectal cancer, based on review of more than 400 epidemiological studies -- while red meat was classified separately as Group 2A (probably carcinogenic), a weaker designation with less-settled evidence. IARC attributes meat-associated cancer risk to mechanisms other than IGF-1, including heterocyclic aromatic amines and polycyclic aromatic hydrocarbons formed during high-heat cooking, and N-nitroso compounds formed during processing/preservation. By focusing the discussion on IGF-1 as a non-carcinogenic growth-promoter, the claim omits the primary mechanisms and the Group 1 classification underlying the established processed-meat-cancer link, making the 'not necessarily true' framing misleading for processed meat, though closer to defensible for unprocessed red meat where evidence is weaker.